Globus Medical(GMED)
搜索文档
Globus Medical (GMED) is an Incredible Growth Stock: 3 Reasons Why
ZACKS· 2025-11-15 02:46
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great growth stock is not easy at all.That's because, these stocks usually carry above-average risk and volatility. In fact, betting on a stock for which the growth story is actually over or nearing its end could lead to significant loss.However, it's pretty easy to find cutting-edge growth stocks with the help of the Z ...
Medical Products Leader In Base After 36% Stock Surge On Blowout Quarterly Earnings
Investors· 2025-11-14 23:15
BREAKING: Stocks Drop As Netflix, Bristol Myers Slide Globus Medical (GMED) stock rocketed up more than 30% in one November session after the medical products maker delivered accelerating growth in its third-quarter earnings report. Now, shares are building the right side of a 42-week-long cup base, according to pattern recognition tools on Investor's Business Daily's MarketSurge, making Globus Medical a stock to watch. The stock's relative strength line… Related news Globus Medical Sees Composite Rating Cl ...
Globus Medical: Straightening Its Back
Seeking Alpha· 2025-11-11 23:00
If you like to see more ideas, please subscribe to the premium service "Value in Corporate Events" here and try the free trial. In this service we cover major earnings events, M&A, IPOs and other significant corporate events with actionable ideas. Furthermore, we provide coverage of situations and names on request!Over the summer, I concluded that Globus Medical ( GMED ), deserved my backing again after shares had come under great pressure following a soft first quarter earnings report, while investors were ...
Undervalued Cannabis Stocks to Watch in November 2025
Marijuana Stocks | Cannabis Investments And News. Roots Of A Budding Industry.™· 2025-11-11 23:00
行业整体态势 - 大麻行业持续吸引投资者关注,许多公司专注于扩张、品牌发展和运营效率提升 [1] - 行业适应消费者需求变化、州级市场竞争和监管环境演变,州级层面的扩张支持行业逐步增长 [2] - 多家公司强调成本控制和利润率改善,这有助于长期业绩稳定 [2] 重点公司概览 - **Glass House Brands Inc (GLASF)**: 垂直整合公司,业务集中于加州,重点是大规模温室种植和零售业务,通过战略收购扩大零售版图 [4] - **Ascend Wellness Holdings Inc (AAWH)**: 多州运营商,业务涵盖种植、加工和品牌零售店,产品线覆盖价值型、中端和高端消费群体 [8] - **Planet 13 Holdings Inc (PLNH)**: 以体验式零售闻名,拥有大型娱乐化 dispensary 目的地,并扩展到内华达州以外市场 [10] 公司财务与运营表现 - **Glass House Brands Inc (GLASF)**: 收入因产量增加和批发销售增强而增长,毛利率因温室产量提高和运营浪费减少而上升,每磅种植成本降低 [7] - **Ascend Wellness Holdings Inc (AAWH)**: 收入增长得益于批发业务和新零售店,毛利率因供应链协同和制造效率改善而提高,但持续报告净亏损 [8] - **Planet 13 Holdings Inc (PLNH)**: 收入呈现温和增长,毛利率保持相对稳定但面临运营费用压力,扩张至佛罗里达州带来长期增长潜力 [12]
Globus Medical (GMED) Soars 38.9% on Stellar Q3
Yahoo Finance· 2025-11-10 01:40
股价表现与市场情绪 - 公司股价上周环比飙升389% [1] - 公司被列为上周领涨大盘的重要公司之一 [1] 分析师评级与目标价 - 美国银行证券将公司评级从“中性”上调至“买入” [2] - 美国银行证券将目标价从65美元上调至91美元 较报告前收盘价6171美元有47%的上涨潜力 [2] - 富国银行将目标价从66美元上调至79美元 [3] 第三季度财务业绩 - 第三季度净利润同比飙升129% 从5184万美元增至11897万美元 [3] - 第三季度净销售额同比增长229% 从6257亿美元增至769亿美元 [3] 全年业绩指引 - 公司上调全年收入指引至286亿美元至29亿美元区间 [4] - 新指引的下限286亿美元高于此前指引的28亿美元 [4] 管理层评论 - 总裁兼首席执行官对整体业绩的强劲表现和公司持续进展表示满意 [5] - 公司未来重点是以强劲态势结束2025年 并通过创新、严格执行业务和提供差异化技术来实现持续的有机增长 [5]
Expedia, Sandisk and Penumbra Are Among the Top 10 Large-Cap Gainers Last Week (Nov. 3-Nov. 7): Are the Others in Your Portfolio? Expedia, Sandisk and Penumbra Are Among the Top 10 Large-Cap Gainers L





Benzinga· 2025-11-09 20:08
上周表现优异的大盘股综述 - 上周有十只大盘股表现突出,股价涨幅均超过13% [1] - 所有公司的股价上涨均与发布优于预期的季度财报和/或积极的业绩指引相关 [1] 各公司表现及驱动因素 - Globus Medical Inc (GMED) 股价上涨39.79%,因第三季度财报超预期且上调2025财年指引,并获得多家分析师上调评级 [1] - Sandisk Corporation (SNDK) 股价上涨13.77%,因第一季度财报超预期且第二季度指引高于预估 [1] - Lumentum Holdings Inc (LITE) 股价上涨15.30%,因第一季度财报超预期且第二季度指引高于预估 [1] - Datadog Inc (DDOG) 股价上涨16.91%,因第三季度财报超预期、第四季度指引高于预估且上调2025财年指引 [1] - Expedia Group Inc (EXPE) 股价上涨18.14%,因第三季度盈利超预期且上调2025财年指引 [1] - Coherent Corp (COHR) 股价上涨15.82%,因第一季度财报超预期且第二季度销售指引高于预估 [1] - Penumbra Inc (PEN) 股价上涨19.58%,因第三季度财报超预期且上调2025财年销售指引 [1] - Teva Pharmaceutical Industries Limited (TEVA) 股价上涨15.13%,因第三季度盈利和营收超预期且上调全年每股收益指引 [1] - Madrigal Pharmaceuticals Inc (MDGL) 股价上涨19.90%,因第三季度销售业绩超预期 [1] - DuPont de Nemours Inc (DD) 股价上涨15.80%,因第三季度盈利和营收超预期 [1]
Here's What Stimulated Global Medical's Third-Quarter Blowout
Investors· 2025-11-08 05:10
"Management now expects it to be accretive in 2025 (vs. second year post-close previously)," Saxon said in a note. "GMED continues to integrate NVRO and expects to be largely done around mid-2026." Globus Medical stock shot up 36.1%, closing at 83.89. Shares ended the regular session above their 200-day line at an eight-month high. Globus Medical Stock Jumps On Hiked Outlook Across all segments, Globus' sales grew 6.4% organically to $769 million, topping forecasts for $735 million. Adjusted earnings came i ...
Globus Medical Stock Soars After Earnings. Where It's Seeing the Strength.
Barrons· 2025-11-08 00:08
公司股价表现 - 公司股价正朝着创纪录的最大单日百分比涨幅迈进 [1]
Today’s Market Moving Stocks: Affirm Holdings, Expedia, and Globus Medical
Yahoo Finance· 2025-11-08 00:04
Affirm Holdings (AFRM) 业绩表现 - 股价当日上涨约9%,即5.88美元,得益于强劲的季度业绩 [1] - 每股收益为0.23美元,超出市场预期0.12美元,营收达9.3334亿美元,同比增长33.6%,超出市场预期4998万美元 [1] - 公司上调业绩指引,预计商品交易总额将达到475亿美元,高于此前预期的460亿美元,调整后运营利润率预期上调至27.1%,此前为26.1% [1][7] Expedia Group (EXPE) 业绩与展望 - 股价当日上涨约17%,即37.47美元,受强劲业绩推动 [2] - 公司上调2025年营收增长预期至6%-7%,高于此前预期的3%-5% [2][7] - 第三季度B2B部门预订额增长26%,达到93.8亿美元 [2] Globus Medical (GMED) 业绩与市场观点 - 股价当日上涨约29%,即18美元,受业绩推动 [3] - 每股收益为1.18美元,超出市场预期0.41美元,营收为7.69亿美元,同比增长约23%,超出市场预期3433万美元 [3] - Piper Sandler将公司目标价上调至90美元,评级为增持,主要因盈利能力改善,管理层将改善归因于美国脊柱销售加速和制造计划 [3][4] Akamai Technologies (AKAM) 业绩与展望 - 股价当日上涨约10%,即7.26美元,受业绩推动 [5] - 最近季度每股收益为1.86美元,超出市场预期0.22美元,营收为10.5亿美元,同比增长5%,超出市场预期1000万美元 [5] - 公司预计调整后每股收益为1.65-1.85美元,中值1.75美元高于市场预期的1.65美元,预计销售额为10.65-10.85亿美元,中值10.75亿美元略高于市场预期的10.7亿美元 [6]
Morning Market Movers: MSGM, DTCK, ELDN, TMCI See Big Swings
RTTNews· 2025-11-07 20:26
盘前交易概况 - 美国东部时间周五早上7点15分,盘前交易出现显著活动,多只股票出现早期价格变动,预示着开盘前的潜在机会 [1] - 对于活跃交易者而言,盘前交易有助于抢先发现潜在的价格突破、反转或剧烈波动 [1] - 这些早期走势通常预示着动量可能延续至常规交易时段,使盘前分析成为交易日的关键部分 [1] 盘前涨幅居前股票 - Motorsport Games Inc (MSGM) 股价上涨122%,报4.88美元 [3] - Globus Medical, Inc (GMED) 股价上涨27%,报78.75美元 [3] - JFrog Ltd (FROG) 股价上涨26%,报59.60美元 [3] - FIGS, Inc (FIGS) 股价上涨19%,报8.97美元 [3] - Organogenesis Holdings Inc (ORGO) 股价上涨18%,报4.59美元 [3] - PureCycle Technologies, Inc (PCT) 股价上涨17%,报11.31美元 [3] - Expedia Group, Inc (EXPE) 股价上涨16%,报255.10美元 [3] - 10x Genomics, Inc (TXG) 股价上涨13%,报14.72美元 [3] - Abacus Global Management, Inc (ABL) 股价上涨12%,报5.95美元 [3] - GigaCloud Technology Inc (GCT) 股价上涨9%,报27.80美元 [3] 盘前跌幅居前股票 - Davis Commodities Limited (DTCK) 股价下跌65%,报2.23美元 [4] - Eledon Pharmaceuticals, Inc (ELDN) 股价下跌46%,报2.19美元 [4] - Treace Medical Concepts, Inc (TMCI) 股价下跌35%,报4.00美元 [4] - Energys Group Limited (ENGS) 股价下跌30%,报2.77美元 [4] - Intellia Therapeutics, Inc (NTLA) 股价下跌27%,报8.89美元 [4] - Fox Factory Holding Corp (FOXF) 股价下跌24%,报16.60美元 [4] - Opendoor Technologies Inc (OPEN) 股价下跌24%,报4.94美元 [4] - AirSculpt Technologies, Inc (AIRS) 股价下跌21%,报8.27美元 [4] - Power Solutions International, Inc (PSIX) 股价下跌20%,报64.25美元 [4] - ClearPoint Neuro, Inc (CLPT) 股价下跌17%,报15.00美元 [4]